Skip to main navigation
Go to  NovaBridge Biosciences logo
  • Home
  • About
    • Who We Are
    • Leadership Team
    • Contact
  • Innovation
    • Oncology
    • Ophthalmology (Visara)
    • Publications & Presentations
  • Pipeline
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
    • Externally Sponsored Research
  • News
  • Investors
    • Overview
    • Corporate
      • Corporate Profile
      • Corporate Governance
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations & Webcasts
    • Stock
      • Stock Quote & Chart
      • Historical Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact
  • Careers
  • Search Investors
Go to  NovaBridge Biosciences homepage
  • Home
  • About
    • Who We Are
    • Leadership Team
    • Contact
  • Innovation
    • Oncology
    • Ophthalmology (Visara)
    • Publications & Presentations
  • Pipeline
    • Pipeline
    • Clinical Trials
    • Expanded Access Policy
    • Externally Sponsored Research
  • News
  • Investors
    • Overview
    • Corporate
      • Corporate Profile
      • Corporate Governance
    • News & Events
      • News Releases
      • Event Calendar
      • Presentations & Webcasts
    • Stock
      • Stock Quote & Chart
      • Historical Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
      • Annual Reports
    • IR Resources
      • Investor FAQs
      • Email Alerts
      • Contact
  • Careers

Event Details

Givastomig: Mature Clinical Data and Path to Registrational Development

2026.11.02 8:00 AM EST

Featured Speaker: 

Samuel J. Klempner, M.D., Associate Professor of Medicine at Massachusetts General Hospital and lead investigator of the Phase 1b givastomig study

Format: 

Live webcast followed by Q&A

Register for Webcast
Add to Outlook
Add to Google Calendar

Supporting Materials

ESMO 2026 Poster and Supplemental Efficacy and Safety Analyses

Events

Learn More

News Releases

Learn More

Presentations and Corporate Materials

Learn More

SEC Filings

Learn More

Stock Information

Learn More

Investor Inquiries

Learn More

Sitemap

  • Home
  • About
  • Innovation
  • Pipeline
  • News
  • Investors
  • Careers
  • Language Switcher

Follow Us

  • LinkedIn

Copyright © 2026 NovaBridge Biosciences. All Rights Reserved.

  • Terms of Use
  • Privacy Policy